Truthout
Big Pharma
End Price-Gouging on Drugs Developed With Public Dollars
Why should the drug industry be the exclusive financial beneficiary of research that the public helps fund? The public should benefit as well.
A Surprise Shill for Big Pharma?
Patients groups are the focus of a new report that asks questions about ties to corporate pharmaceutical companies.
The $100,000-Per-Year Pill: How US Health Agencies Choose Pharma Over Patients
Our taxes pay for most of the front end (riskier) research on drugs, so why do private companies get to set the price?
|
Revealed: AARP Is Funding ALEC
AARP isn't exactly hiding its new financial relationship with ALEC.
ALEC 2016 Agenda Boosts Charters, Coal and Other Corporate Funders
Like ALEC, Mike Pence has cast his lot with industry, peddling deceptive claims like smoking doesn't cause cancer and opposing laws to reduce gun violence.
Big Pharma Feels the Bern
The entities that are really getting rich off the commons are the corporations and corporate executives.
|
Monsanto, Bayer and the Push for Corporate Cannabis
Critics note that of the hundreds of millions in tax revenues that AUMA is expected to generate, not a penny will go to the California general fund.
The War on Weed Is Winding Down — but Will Monsanto Be the Winner?
Skeptics question the sudden push for legalization, which is largely funded by wealthy investors linked to Big Ag and Big Pharma.
Feed Me, Pharma: More Evidence That Industry Meals Are Linked to Costlier Prescribing
A third study shows an association between physician drug choices and their interactions with the pharmaceutical industry.
|
Big Pharma Seeks to Capitalize on Pain-Reducing Compound Derived From Cannabis
While regulators debate the cannabis-derived compound CBD's legal status, Big Pharma attempts to corner the market.